← Eichor
Study identifier: NCT06312813 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Evaluating Use of Topical Imipramine and Amitriptyline in Reducing Ultraviolet B Light-Induced Redness in Patients With Rosacea

Condition: Rosacea  ·  Sponsor: Wright State University

PhasePhase 2
Planned participants48
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersYes

About this study

Rosacea is a common skin condition associated with easy blushing and red face; many patients with rosacea react to sunlight with increased redness. The purpose of this study is to determine if the use of a topical medication will help reduce sunlight induced redness and irritation in patients with rosacea.

This description comes directly from the study's public registry record.

Talk to the study team

Manager Clinical Research Operations  ·  (937)-245-7500  ·  pturesearch@wrightstatephysicians.org

Always discuss trial participation with your own doctor first.

Locations (1)

Wright State PhysiciansFairborn, Ohio, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06312813